Category Archives : News

Home  >>  News

DKFZ: Figures for Germany determined for the first time: Avoidable risk factors cause 37 percent of all cancer cases

On September 10, 2018, Posted by , In News, By , , With Comments Off on DKFZ: Figures for Germany determined for the first time: Avoidable risk factors cause 37 percent of all cancer cases

How many cancer cases in Germany are attributable to risk factors that we can influence ourselves? How many cancer cases are linked to cigarette smoking, being overweight or physical inactivity and, thus, are potentially preventable? Scientists from the German Cancer Research Center (DKFZ) have now calculated these figures for Germany…

Heidelberg University: Precise and Highly Efficient Gene Repair

On August 30, 2018, Posted by , In News, By , , With Comments Off on Heidelberg University: Precise and Highly Efficient Gene Repair

Heidelberg researchers develop new CRISPR/Cas process using Japanese ricefish   Photo: Gutierrez-Triana, Tavhelidse, Thumberger et al., 2018, figure three, subject to CC BY 4.0 license. Medaka embryo, in which the Rx2 gene – a gene critical for eye development – was edited with a repair copy. This copy contains the…

Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

On August 29, 2018, Posted by , In News, By , , With Comments Off on Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales. Affimed will apply its proprietary Redirected Optimized Cell Killing (ROCK®) platform, which enables the generation of both NK cell and T cell-engaging antibodies, to…

Heidelberg University: Protection For Nerve Cells Delivered Through The Nose

On August 27, 2018, Posted by , In News, By , , With Comments Off on Heidelberg University: Protection For Nerve Cells Delivered Through The Nose

Material and picture: Dr Bettina Buchthal. Brain sections of control-treated (bottom) and nasal Activin A-treated (top) mice after a stroke. The white line marks the border between the healthy and damaged brain regions. Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the…

HS-Analysis: how softwares can contribute to cancer treatment development

On August 23, 2018, Posted by , In News, By , , With Comments Off on HS-Analysis: how softwares can contribute to cancer treatment development

Finding a cure to any type of cancer is one of the biggest challenge in medicine. HS-Analysis wants to bring the concer research forward with the help of a software. Read about the plans of Sergey Biniaminov (Managing Director of HS Analysis) in the interview with ka-news (in German).

EMBL: New approach for testing cancer drug response

On August 23, 2018, Posted by , In News, By , , With Comments Off on EMBL: New approach for testing cancer drug response

  New approach uses inherited genome to test cancer drug response. PHOTO: iStock Large-scale systematic analysis explores how inherited genome effects drug response of cancer cells Patients with seemingly similar cancer tumours can respond differently to the same treatment. Over the last decades, scientists have been studying the molecular signatures…

Triple ERC success for DKFZ junior researchers

On August 15, 2018, Posted by , In News, By , , With Comments Off on Triple ERC success for DKFZ junior researchers

The European Research Council (ERC) awards Starting Grants to support excellent young scientists when they are starting an independent science career. In this year’s round of proposals, three scientists from the German Cancer Research Center (DKFZ) have been chosen at once for the prestigious award: Ana Banito, Fabian Erdel and…

FAZ: Heidelberg attracts researchers and physician

On August 15, 2018, Posted by , In News, With Comments Off on FAZ: Heidelberg attracts researchers and physician

The Frankfurter Allgemeine Zeitung recently published an article about the biotech/life science cluster that developed around the region of Heidelberg in the past decades. André Domin (Managing Director of the Technology Park Heidelberg and member of the BioRN Network e.V. executive board) reported on the funding for the new technology…

DKFZ: Combined imaging provides more information about the tumor

On August 13, 2018, Posted by , In News, By , , With Comments Off on DKFZ: Combined imaging provides more information about the tumor

The German Cancer Research Center (DKFZ) has installed the world’s first combined device combining a 9.4 Tesla high-field MRI with a PET scanner. In combination, the two imaging methods provide significantly more information about tumors. © S. Kegel/DKFZ A variety of imaging procedures provide insights into the body’s interior. Each…

Fraunhofer IGB: Third place for Retina-on-a-chip project at the Science2Start competition

On July 30, 2018, Posted by , In News, By , , With Comments Off on Fraunhofer IGB: Third place for Retina-on-a-chip project at the Science2Start competition

At the annual Science2Start competition organized by BioRegio STERN Management GmbH, Dr. Ing. Christopher Probst, scientist in the Organ-on-a-Chip group of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, reached place 3 with the Retina-on-a-Chip project. With “Retina-on-a-Chip”, scientists at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB…